128 related articles for article (PubMed ID: 547656)
1. Electroencephalographic study of pentazocine and buprenorphine.
Kubicki S; Azcona A
Acta Anaesthesiol Belg; 1979; 30 Suppl():123-33. PubMed ID: 547656
[TBL] [Abstract][Full Text] [Related]
2. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].
Hiyama T; Shintani S; Tsutsui M; Yasuda Y
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817
[TBL] [Abstract][Full Text] [Related]
3. [Interactions between buprenorphine, narcotic analgesic, and centrally acting drugs in prolongation of halothane-induced sleeping and analgesia (author's transl)].
Yasuda Y; Shioya Y; Nakai S; Shintani S; Hiyama T
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):163-72. PubMed ID: 6123474
[TBL] [Abstract][Full Text] [Related]
4. Proceedings: The effects of buprenorphine, morphine and pentazocine on turning behaviour and stereotypy induced by apomorphine in the rat.
Cowan A; Dettmar PW; Walter DS
J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():15P. PubMed ID: 2687
[No Abstract] [Full Text] [Related]
5. [Morphine antagonists (pentazocine, nalorphine, naloxone and buprenophine)].
Fournier T; Besserve P; Lefèvre P; Lephay A; Ossart M
Cah Anesthesiol; 1988 May; 36(3):223-34. PubMed ID: 2840178
[No Abstract] [Full Text] [Related]
6. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
Shannon HE; Cone EJ; Gorodetzky CW
J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
[TBL] [Abstract][Full Text] [Related]
7. Effects of morphine, buprenorphine, pentazocine and nalorphine on acquisition and extinction of active avoidance responses in rats.
Saha N; Datta H; Sharma PL
Indian J Physiol Pharmacol; 1990 Jul; 34(3):179-82. PubMed ID: 2286420
[TBL] [Abstract][Full Text] [Related]
8. [Effect of agonistic morphine antagonists (cyclazocine, butorphanol, buprenorphine) on EEG activity and the depth of anesthesia in rats].
Ogawa T; Sano Y; Hirabayshi Y; Yoshikawa H; Wauquier A; Cuesta P; Clinken B; William M; Van den Broeck
Masui; 1987 Apr; 36(4):490-7. PubMed ID: 3613060
[No Abstract] [Full Text] [Related]
9. Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine.
France CP; Jacobson AE; Woods JH
NIDA Res Monogr; 1984 Mar; 49():136-42. PubMed ID: 6207431
[No Abstract] [Full Text] [Related]
10. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
Malec D; Fidecka S; Langwiński R
Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
[TBL] [Abstract][Full Text] [Related]
11. [The effects of low-doses of fentanyl, buprenorphine and pentazocine on circulatory responses to endotracheal intubation].
Adachi Y; Takamatsu I; Harada M; Uchihashi Y; Karasawa F; Sato T; Sugahara S
Masui; 1998 Dec; 47(12):1478-81. PubMed ID: 9990217
[TBL] [Abstract][Full Text] [Related]
12. Negative reinforcing properties of naloxone in the non-dependent rhesus monkey: influence on reinforcing properties of codeine, tilidine, buprenorphine, and pentazocine.
Hoffmeister F
Psychopharmacology (Berl); 1986; 90(4):441-50. PubMed ID: 3101099
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
Lamas X; Farre M; Cami J
J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
[TBL] [Abstract][Full Text] [Related]
14. Comparative cardiac contractile actions of six narcotic analgesics: morphine, meperidine, pentazocine, fentanyl, methadone and l-alpha-acetylmethadol (LAAM).
Rendig SV; Amsterdam EA; Henderson GL; Mason DT
J Pharmacol Exp Ther; 1980 Oct; 215(1):259-65. PubMed ID: 6109016
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological properties of buprenorphine, a new analgesic agent. Part II. (author's transl)].
Shintani S; Umezato M; Toba Y; Yamaji Y; Kitaura K; Tani T; Ishiyama H; Kikuchi T; Mori T; Nakai S; Watanabe K; Hiyama T
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):173-91. PubMed ID: 6123475
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.
Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1979 Feb; 17(2):81-110. PubMed ID: 378645
[TBL] [Abstract][Full Text] [Related]
17. Interactions of opioids with caffeine: evaluation by ambulatory activity in mice.
Kuribara H; Uchihashi Y
J Pharm Pharmacol; 1994 Feb; 46(2):141-4. PubMed ID: 8021804
[TBL] [Abstract][Full Text] [Related]
18. Effects of buprenorphine on shock titration in squirrel monkeys.
Dykstra LA
J Pharmacol Exp Ther; 1985 Oct; 235(1):20-5. PubMed ID: 4045722
[TBL] [Abstract][Full Text] [Related]
19. Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.
Kuhn DM; Greenberg I; Appel JB
J Pharmacol Exp Ther; 1976 Jan; 196(1):121-7. PubMed ID: 1246006
[TBL] [Abstract][Full Text] [Related]
20. Studies on the quantitative antagonism of analgesics by naloxone and diprenorphine.
Takemori AE; Hayashi G; Smits SE
Eur J Pharmacol; 1972 Oct; 20(1):85-92. PubMed ID: 4637947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
